Detalles de la búsqueda
1.
Efficient chimeric antigen receptor targeting of a central epitope of CD22.
J Biol Chem
; 299(7): 104883, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37269947
2.
Asciminib stands out as the superior tyrosine kinase inhibitor to combine with anti-CD20 monoclonal antibodies for the treatment of CD20+ Philadelphia-positive B-cell precursor acute lymphoblastic leukemia in preclinical models.
Haematologica
; 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38841802
3.
Philadelphia Chromosome-Positive Leukemia in the Lymphoid Lineage-Similarities and Differences with the Myeloid Lineage and Specific Vulnerabilities.
Int J Mol Sci
; 21(16)2020 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32806528
4.
HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies.
Blood
; 130(14): 1628-1638, 2017 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28830887
5.
Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents.
Br J Cancer
; 119(7): 873-884, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30287919
6.
Inhibition of protein disulfide isomerase induces differentiation of acute myeloid leukemia cells.
Haematologica
; 103(11): 1843-1852, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30002127
7.
Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy.
BMC Cancer
; 18(1): 210, 2018 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29463237
8.
Typical and Atypical Inducers of Lysosomal Cell Death: A Promising Anticancer Strategy.
Int J Mol Sci
; 19(8)2018 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30071644
9.
New insights into redox homeostasis as a therapeutic target in B-cell malignancies.
Curr Opin Hematol
; 24(4): 393-401, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28402987
10.
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death.
EMBO J
; 31(5): 1062-79, 2012 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-22252128
11.
Adenanthin, a new inhibitor of thiol-dependent antioxidant enzymes, impairs the effector functions of human natural killer cells.
Immunology
; 146(1): 173-83, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26094816
12.
Advancements in cancer immunotherapies targeting CD20: from pioneering monoclonal antibodies to chimeric antigen receptor-modified T cells.
Front Immunol
; 15: 1363102, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38638442
13.
Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia-positive lymphoid leukemia to tyrosine kinase inhibitors.
Hemasphere
; 8(3): e56, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38486859
14.
CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies.
Oncoimmunology
; 13(1): 2362454, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38846084
15.
Prenyltransferases regulate CD20 protein levels and influence anti-CD20 monoclonal antibody-mediated activation of complement-dependent cytotoxicity.
J Biol Chem
; 287(38): 31983-93, 2012 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-22843692
16.
DNA intercalation without flipping in the specific ThaI-DNA complex.
Nucleic Acids Res
; 39(2): 744-54, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20861000
17.
Alteration of the -35 and -10 sequences and deletion the upstream sequence of the -35 region of the promoter A1 of the phage T7 in dsDNA confirm the contribution of non-specific interactions with E. coli RNA polymerase to the transcription initiation process.
Front Mol Biosci
; 10: 1335409, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38259683
18.
CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies.
Cells
; 11(11)2022 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35681499
19.
Immune Evasion as the Main Challenge for Immunotherapy of Cancer.
Cancers (Basel)
; 14(15)2022 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35892880
20.
A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia.
Front Immunol
; 13: 781364, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35296093